SCHEMBL14764293

SCHEMBL14764293

CC(Cl)C(=O)Nc1cccc(Br)c1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ KMT2A Q03164 6/20 0.42
▸ MEN1 O00255 5/20 0.40
▸ CXCR1 P25024 1/20 0.40
▸ CXCR2 P25025 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ ATM Q13315 1/20 0.39
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ LMNA P02545 5/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ ANPEP P15144 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14764227 0.77 L3MBTL1 (0.50) TP53GAAL3MBTL1KMT2AMEN1
SCHEMBL1496397 0.76 TP53 (0.42) TP53GAAKMT2AMEN1CXCR1
SCHEMBL14764443 0.76 ALDH1A1 (0.50) TP53GAAKMT2AMEN1CXCR1
SCHEMBL15228630 0.76 ALDH1A1 (0.50) TP53GAAKMT2AMEN1CXCR1
SCHEMBL7881974 0.74 ALDH1A1 (0.44) TP53GAAKMT2AMEN1CXCR1
SCHEMBL31577354 0.74 ALDH1A1 (0.44) TP53GAAKMT2AMEN1CXCR1
SCHEMBL31383892 0.73 KMT2A (0.40) TP53GAAKMT2AMEN1CXCR1
SCHEMBL28785699 0.73 TP53 (0.41) TP53GAAL3MBTL1KMT2AMEN1
SCHEMBL17268395 0.71 HCAR3 (0.46) TP53GAAL3MBTL1KMT2AMEN1
SCHEMBL17269792 0.71 GAA (0.39) TP53GAAL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 — — WO disclosed
Send feedback